A previous mutational analysis of erabutoxin a (Ea), a curaremimetic toxin from sea snake venom, showed that the substitutions S8G and S8T caused, respectively, 176-fold and 780-fold affinity decreases for the nicotinic acetylcholine receptor (AchR). In view of the fact that the side-chain of Ser8 is buried in the wild-type toxin, we wondered whether these affinity changes reflect a direct binding contribution of S8 to the receptor and/or conformational changes that could have occurred in Ea as a result of the introduced mutations. To approach this question, we solved X-ray structures of the two mutants S8G and S8T at high resolution (0.18 nm and 0.17 nm, with R factors of 18.0% and 17.9%, respectively). The data show that none of the mutations significantly modified the toxin structure. Even within the site where the toxin binds to the receptor the backbone conformation remained unchanged. Therefore, the low affinities of the mutants S8T and S8G cannot be explained by a large conformational change of the toxin structure. Although we cannot exclude the possibility that undetectable structural changes have occurred in the toxin mutants, our data support the view that, although buried between loop I and II, S8 is part of the functional epitope of the toxin.Keywords: curaremimetic toxins; nicotinic acetylcholine receptor; X-ray structure.Mutational analyses are widely used to identify the functional surfaces of proteins and to determine the contribution of interacting residues to the energetic stabilization of protein± protein complexes [1,2]. In most cases, it is assumed that the introduced mutations have little, if any, effect on the protein conformation, leading authors to conclude that affinity decreases occurring as a result of mutations are likely to reflect a direct contribution of the mutated residue to protein interaction [3]. In general, this conclusion appears to be correct, especially when it is supported by crystallographic data that indicate that the mutated residue establishes contacts with the interacting partner [3,4]. However, the situation may be more complex, as some mutations cause affinity decreases even though the mutated residue is not in the region contacting the receptor [4]. Therefore, in the absence of information regarding the three-dimensional structure of a protein±protein complex, the effect of some mutations should be considered with caution, the introduced mutation causing possibly local or even more global conformational changes in the protein. One way to tentatively clarify a doubtful case consists of elucidating the three-dimensional structure of the mutant and comparing it with that of the wild-type protein. This situation has been met with mutations introduced at position 8 of erabutoxin a (Ea), a snake curaremimetic toxin, the functional site of which has been identified on the basis of extensive mutational analyses [5,6].Ea is a small protein of 62 amino acids that belongs to the family of short-chain curaremimetic toxins [7], which bind to the nicotinic acetylcholine recept...